Adhesive interactions are critical for the proliferation, survival and function of all cells. Integrin receptors as the major family of adhesion receptors have been the focus of study for more than a decade. These studies have tremendously enhanced our understanding of the integrin-mediated adhesive interactions and have unraveled novel integrin functions in cell survival mechanisms and in the activation of divergent signaling pathways. The signals from integrin receptors are integrated from those originating from growth factor receptors in order to organize the cytoskeleton, stimulate cell proliferation and rescue cells from matrix detachment-induced programmed cell death. These functions are critical in the regulation of multiple processes such as tissue development, in¯ammation, angiogenesis, tumor cell growth and metastasis and programmed cell death.
Introduction
The term Integrin was coined about a decade ago to describe cell surface receptors that mediate cellular adhesion to extracellular matrix proteins and to other cells (Tamkun et al., 1986; Ruoslahti and Pierschbacher, 1987) . However, it has become clear that the biological signi®cance of integrin-mediated adhesive events goes beyond simple physical linkage of cells to extracellular matrix proteins or to other cells. Adhesion is shown to be important for survival and proliferation of various cell types (Hynes, 1994; Ruoslahti and Reed, 1994; Meredith et al., 1993; Meredith and Schwartz, 1997) . A remarkable number of classical signaling pathways are now known to be activated by interactions of cells with matrix proteins via integrins (Juliano and Haskill, 1993; Schwartz et al., 1995; Clarke and Brugge, 1995) . Regulation of adhesion by integrins is also central to a number of specialized pathways in the hematopoietic systems, allowing attachment of platelets to soluble ligands and of lymphocytes to antigen-presenting cells and the phagocytosis of complement opsonized targets by granulocytes and macrophages. Cell-matrix interactions result in a cascade of cellular responses which ultimately promote not only cell binding but also lead to cell spreading. Both cell attachment and spreading are critical for cell survival because cells that adhere, but can not spread, may undergo programmed cell death (Bates et al., 1994; Re et al., 1994) Integrin receptors are composed of noncovalently associated a and b chains which form heterodimeric receptor complexes (Hynes, 1992; Ruoslahti, 1991 Ruoslahti, , 1996 . The a and b subunits contain a large extracellular domain, a short transmembrane domain and a cytoplasmic carboxy terminal domain of variable length. The extracellular domains of both the a and b chains form the ligand binding domain. In mammals, 17 a subunits and 8 b subunits are known. These a and b subunits heterodimerize to produce 22 dierent receptors (Figure 1 ). Despite this high degree of redundancy, most integrins seem to have speci®c biological functions raising the possibility of signaling dierences between integrins. Integrins not only bind ligands present in the extracellular matrix such as ®bronectin, collagen, vitronectin etc., certain integrins can also bind to soluble ligands such as ®brinogen or to counter-receptors such as intracellular adhesion molecules (ICAMs) on adjacent cells.
Many of the integrins recognize the RGD (Arg-GlyAsp) sequence in their matrix ligands (Ruoslahti, 1996) . Nevertheless, they are capable of distinguishing dierent RGD-containing proteins such that some bind primarily to ®bronectin and others to vitronectin. Integrins are also expressed in a cell-type speci®c manner; thus one group of integrins such as a 5 b 1 , a v b 3 and a v b 6 is associated with migration and proliferation in various cell types. Many other integrins are expressed in selective cell types. Examples of cell-type speci®c integrins include a IIb b 3 in platelets and a 6 b 4 in epithelial cells. Integrins are capable of generating both common signals and signals speci®c for individual integrins. The signals from these integrin receptors are integrated with those originating from growth factor and cytokine receptors in order to organize the cytoskeleton, stimulate mitogen activated protein (MAP) kinase cascades and regulate immediately early gene expression. It has also been recognized that information can also¯ow in the reverse direction; the integrin ligand binding activity is also regulated from the inside of the cell (Schwartz et al., 1995; Kolamus and Seed, 1997) . Thus integrin receptors are highly versatile proteins mediating a variety of biological processes.
In this review, I will summarize the recent studies on three signaling pathways activated by integrin receptors. Speci®cally the role of integrins in (1) cytoskeletal organization, (2) in cell proliferation signaling pathways and (3) in cell survival pathways will be reviewed. A brief summary of the role of integrins in cell transformation and therapeutic applications is also included. the formation of structures at the cell membrane known as focal adhesions where integrins link the outside matrix to intracellular cytoskeletal complexes (Burridge et al., 1988) . These protein assemblies play an important role in modulating cell adhesion and inducing cell shape changes involved in cell spreading and locomotion. Focal adhesion complexes are readily seen by immuno¯uoresence as tear shaped plaques at the ends of actin ®lament based stress ®bers. A diverse number of structural and signaling proteins, such as integrins, cytoskeletal proteins, protein kinases and signaling molecules are known to be concentrated at these sites (Craig and Johnson, 1996; Yamada and Miyamoto, 1995; Lo and Chen, 1994) (Figure 2 ). Actin binding proteins that colocalize with integrins at focal adhesion plaques include, a-actinin, talin, tensin, paxillin, vinculin and tensin. Protein kinases that colocalize with these structures include focal adhesion kinase (FAK), c-src, protein kinase C and integrin linked kinase (ILK) etc., (Yamada and Miyamoto, 1995; Dedhar and Hannigan, 1996) .
Focal adhesion kinase
Unlike growth factor receptors, integrins lack intrinsic tyrosine kinase activity. Yet, an early event during integrin signaling is the tyrosine phosphorylation of the non-receptor tyrosine kinase, FAK in response to cell adhesion Richardson and Parsons, 1995; . All b 1 and a v containing integrins share the ability to promote the assembly of focal adhesions and activate FAK. FAK is an unusual nonreceptor tyrosine kinase and lacks src homology (SH)2 and SH3 domains. The mechanism by which integrins activate FAK is incompletely understood. It is clear that this process is tightly coupled to the process of assembly of focal adhesion complexes. The phosphorylation of FAK is believed to initiate a cascade of phosphorylation events and new protein interactions required for adhesion-dependent signaling complexes. Talin binds directly to the carboxy-terminal domain of FAK (Chen et al., 1995) and also interacts with vinculin and thereby paxilin (Brown et al., 1996) . Paxilin in turn binds to a distinct site in the carboxy terminus of FAK . Thus it is believed that the initial recruitment of FAK to activated integrins is indirect and mediated by talin. It is proposed that upon recruitment to focal adhesion complexes by talin, FAK undergoes conformational change and interacts through its amino terminal domain with the b subunit tail. The amino terminal domain of FAK plays a negative autoregulatory role, possibly by folding back onto the catalytic domain (Richardson and Parsons, 1996) . Thus the conformational transition may be a prerequisite for FAK's catalytic activity. Integrin aggregation by ligand binding would then result in oligomerization of FAK and activation of FAK by trans-autophosphorylation. Autophosphorylation of FAK at residue 397 results in the binding of SH2 domain of Src and Fyn . The Src family kinases such as Src and Fyn then phosphorylate a number of FAK-associated proteins including paxilin, tensin and p 130 CAS . Src can also phosphorylate FAK at tyrosine residue 925, creating a binding site for the Grb2-mSOS complex . Finally autophosphorylated FAK can combine with and activate phosphatidyl-inositide-3 kinase (PI-3K) (Chen et al., 1996) . FAK is thus linked to a number of intracellular signaling pathways. The analysis of FAK knockout mice has provided important information on the biological function of FAK. Embryonic ®broblasts derived from these mice form numerous small focal contacts, but fail to form the large peripheral focal adhesions and these cells Figure 2 Model for the arrangements of dierent proteins in a focal adhesion complex. Arrangements of cytoskeletal proteins that colocalize to focal adhesion complexes in vivo and bind to integrins in vitro are shown. Ligand occupancy, integrin aggregation and tyrosine phosphorylation lead to the accumulation of F-actin and associated cytoskeletal proteins in a massive adhesive and signaling complex. ECM: Extracellular matrix, RGD: Arg-Gly-Asp, JNK: Jun Kinase migrate less eciently than control cells (Ilic et al., 1995) . The observation that overexpression of FAK increases cell migration while a dominant negative form of the kinase inhibits it are also consistent with a role for this kinase in dynamic regulation of focal adhesions during cell migration (Cary et al., 1996; Gilmore and Romer, 1996) .
In contrast to FAK which is activated in response to cell adhesion, the activity of the serine/threonine-kinase termed integrin-linked kinase (ILK) appears to be inhibited in response to integrin ligation. ILK was originally isolated in the yeast two hybrid system by virtue of its ability to interact with the integrin b1 subunit Dedhar and Hannigan, 1996) . ILK also colocalizes to the focal adhesions like FAK. In contrast to FAK, ILK can be readily coimmunoprecipitated with various b integrins Radeva et al., 1997) . Overexpression of ILK in epithelial cells has been shown to induce anchorage-independent growth and malignant transformation (Radeva et al., 1997) . A third protein termed b 3 endonexin has also been identi®ed from yeast two hybrid screens as a b 3 interacting protein (Shattil et al., 1995) . The physiological role of b 3 endonexin is currently unknown.
Role of Rho family of proteins in focal adhesion assembly
Alan Hall's group was the ®rst to describe the assembly of focal adhesions and stress ®bers in serum starved Swiss 3T3 cells. These cells retain few stress ®bers and are devoid of focal adhesions and its components. Readdition of serum or LPA stimulates the formation of stress ®bers and focal adhesion complexes within 2 ± 5 min Nobes and Hall, 1995) . Other growth factors such as platelet derived growth factor (PDGF), epidermal growth factor (EGF) insulin, bombesin also stimulate focal adhesion assembly, but with a longer time course. The induction of a variety of cortical actin assemblies can be ascribed to the action of individual Rho proteins. Rho family of proteins are RAS-related GTP binding proteins consisting of Rho A, B, C, D and E; Racs 1 and 2 and Rac E; and Cdc42, Rho G and TC10 (Van Aelst and D'SouzaSchorey, 1997; Hall, 1998) . Rho is involved in the organization of focal adhesions and stress ®bers in response to LPA; Rac is directly responsible for the membrane ruing and extension of lamellipodia and Cdc42 uniquely controls the formation of ®lipodia (Hall, 1994 (Hall, , 1998 Van Aelst and D'Souza-Schorey, 1997) . There is evidence for the interconnection of these family members in a hierarchial manner: Cdc42 activates Rac and Rac activates Rho.
In addition to the growth factor receptors, Rho family members can also be activated by integrin ligation and clustering. Hotchin and Hall (1995) have demonstrated that the interaction of integrins with extracellular matrix is not sucient to induce integrin clustering and focal complex formation, but requires the activity of Rho family members. The molecular basis for this regulation is not clear but may involve eector proteins which associate with and become activated by GTP-bound RhoA. Two lines of evidence support the notion that integrins can activate Rho. It has been known for some time that integrins can stimulate the production of Phosphatidyl Inositol biphosphate (PIP 2 ) and recent studies have provided evidence that this eect is mediated by Rho (Chong et al., 1994; Hartwig et al., 1995) , possibly through its interaction with a type I isoform of phosphatidyl inositol 4-phosphate 5-kinase (PIP4-5K) (Ren et al., 1996) . The increase in PIP 2 synthesis by Rho A is potentially relevant to focal adhesion assembly because the actin binding activity of several cytoskeletal proteins such as pro®lin and gelsolin is modulated by PIP 2 in vitro (Hartwig et al., 1995) and PIP 2 is enriched in focal adhesion plaques. In light of this, Gilmore and Burridge (1996) reported that the association of PIP 2 with vinculin induces a conformational change in vinculin, allowing it to interact with talin, which binds actin. Furthermore they showed that injection of anti-PIP 2 antibodies into ®broblasts inhibited LPA/Rhoinduced stress ®bers and focal adhesion formation, suggesting a role for PIP 2 in focal adhesion and stress ®ber assembly. Second, dominant negative Rho has been shown to partially suppress the activation of ERK in response to ligation of integrins, suggesting that a Rho regulated pathway is necessary for the full activation of ERK following integrin mediated cell adhesion (Renshaw et al., 1996) .
How does activation of Rho A lead to recruitment of Focal adhesion proteins and assembly of focal adhesion? This question still remains unanswered completely. However, exciting progress has been made in recent years. The involvement of phosphoinositide kinases in Rho signaling has been reported. The eector proteins for Rho A include PIP4-5K, the recently identi®ed serine/threonine kinase Rho-associated coil-coil containing protein kinase (ROCK) and protein kinase N which all associate with and are activated by RhoA (Amano et al., 1997; Van Aelst and D'Souza-Schorey, 1997) . In addition, the p190 Rho GTPase-activating protein (GAP) may also regulate integrin-clustering (Settleman et al., 1992) . Constitutive activation of p190 Rho-GAP disrupts integrin clustering and focal plaque formation. PI-3 kinase which phosphorylates PI(4) phosphate (PIP) or PI(4,5) biphosphate (PIP2) to generate PI (3,4)P 2 or PI (3,4,5)P 3 respectively has been shown to associate with integrin-associated focal adhesion complexes (Chen et al., 1996) . The SH2 domain of the p85 subunit of PI-3 K may be important for its association with tyrosine phosphorylated FAK. The role of PI3K in integrin induced changes in cell behaviour is not understood; however the evidence that inhibition of PI-3 K blocks growth factor induced actin arrangements suggests a possible involvement in integrin regulated cytoskeletal rearrangements.
Rho can also activate a serine/threonine protein kinase known as Rho Kinase, which plays an important role in the assembly of focal adhesions (Amano et al., 1997) . This kinase phosphorylates the myosin binding subunit (MBS) of myosin light chain phosphatase, thereby suppressing the activity of the enzyme . The resulting increase in myosin light chain phosphorylation is believed to induce a conformational change in myosin, thereby increasing its binding to actin ®laments and promote actomyosin contractility and formation of focal complexes and stress ®bers (Chirzanowska-Wondnicka et al., 1996) . More recently, evidence has been presented that Rho kinase can also phosphorylate MLC at the same site phosphorylated by MLC kinase . A model proposed for integrinmediated and Rho-induced stress ®ber formation is depicted in Figure 3 .
In addition to the Rho family members, R-Ras, a GTP-binding protein homologous to Ha-Ras but with activities distinct from those of the transforming RAS proteins, has been shown to activate integrins. Expression of constitutively active R-Ras induced suspension cells to adhere to the extracellular matrix proteins by converting integrins from a low anity to a high anity state (Zhang et al., 1996) . Dominant negative R-Ras reduced the adhesiveness of cells suggesting that endogenous R-Ras can control integrin-ligand anity states. The molecular basis for this regulation is not understood at the present time.
Role of integrins in cell-proliferation signaling pathways
In addition to growth factors and nutrients, many normal cells require adhesion to the extracellular matrix to proliferate. The adhesion-dependent activation of MAP kinase appears to be important in the pathway by which integrins regulate cell proliferation. A number of signaling proteins have been found to be associated with the focal adhesion complexes suggesting the involvement of integrin engagement in the activation of signaling pathways. It is now generally accepted that the activation of ERK in response to integrin ligation requires Ras signaling Wary et al., 1996) . Evidence is presented that certain integrins such as the laminin receptor a 6 b 4 , the lamin/collagen receptor a 1 b 1 , the ®bronectin receptor a 5 b 1 and the vitronectin receptor a v b 3 are linked to the RAS-ERK signaling pathway by the adaptor protein Shc (Wary et al., 1996; Giancotti, 1997) . Shc is an SH2 and phosphotyrosine binding (PTB) domain adaptor protein which links tyrosinephosphorylated signal transducers to Ras (Pawson, 1995) . Upon recruitment to activated receptors, Shc is phosphorylated on tyrosine and binds to the Grb2-mSOS complex. This process results in the juxtaposition of the GTP exchange factor domain of mSOS to RAS, leading to its activation. The role of FAK in the activation of RAS-ERK pathway is not clearly established. Ligation of a 1 b 1 , a 5 b 1 and a v b 3 integrins which are all linked to Shc results in Erk activation, but ligation of other integrins does not produce this eect, even though FAK is stimulated (Wary et al., 1996) . A dominant negative mutant Shc was found to suppress ERK activation in response to integrin ligation (Wary et al., 1996) , but two distinct dominant-negative mutants of FAK do not (Lin et al., 1997; Giancotti, 1997) . These results indicate that Shc is necessary and sucient to link speci®c integrins to the RAS-ERK signaling pathway. However, they do not exclude the possibility that FAK may cooperate with Shc to fully activate ERK in response to integrin ligation. As discussed above, integrin-mediated adhesion signals the autophosphorylation of FAK on Tyrosine 397, generating a binding site for SH2 domains of Src and related kinases (Calab et al., 1995) . The further phosphorylation of FAK at Tyr 925, presumably by Src generates a binding site for the SH2 domain of the adaptor protein GRB2 (Schlaepfer et al., 1994) . GRB2 signals through the RAS GDP/ GTP exchange protein SOS, which has also been detected in the adhesion-dependent focal adhesion complexes containing FAK, GRB2 and c-Src (Yamada and Miyamoto, 1995) (Figure 4) . The activation of RAS-ERK pathway by integrin ligation has been shown to require an intact cytoskeleton suggesting that the integrin-dependent cytoskeletal complexes are instrumental in the activation of the MAP kinase pathway.
MAP kinase in turn activates a number of transcription factors such as SRF, c-Myc that are involved in regulating growth and dierentiation. Studies have shown that in primary cells, engagement of integrins linked to Shc activates transcription from the serum response element (SRE) and promotes progression through the G1 phase of the cell cycle in response to growth factors. Since growth factors also stimulate the RAS-MAP kinase pathway, it is likely that the integrins and growth factor receptors may synergize to enhance RAS-MAP kinase activation.
In addition to the participation of integrins in the activation of the RAS-ERK pathway via Shc, recent studies have shown that speci®c integrins may also cooperate with growth factor receptors directly. The a v b 3 integrin receptor has been found to uniquely associate with cytoplasmic signal transduction mediators of the insulin (and insulin like growth factor, (IGF) receptors (Vuori and Ruoslahti, 1994) . One such signal transduction mediator is insulin receptor substrate (IRS)-1. IRS-1 is tyrosine phosphorylated by the activated insulin (and IGF) receptor and as a result binds a number of other signaling molecules. In Figure 3 Signaling pathways involving integrin receptors and Rho family GTPases leading to focal adhesion complex and actin stress ®ber formation. The integrins activate Rac via Ras and PI-3K and Rho through unknown mechanisms. Rac can also be activated by growth factors such as EGF, PDGF, and Insulin and Rho can be activated by LPA. Rac can also weakly activate Rho by an unknown mechanism. Rac and Rho interact with a number of target eectors. Some of these such as Por1, PIP-5Kinase and Rho kinase are responsible for organizing cytoskeletal structures such as lamellipodia and focal adhesions cells that have adhered to a substrate, such as vitronectin through the a v b 3 integrin, a subset of IRS-1 binds to the integrin. This interaction substantially enhances the growth stimulating eects of insulin and IGF. This interaction appears to be speci®c to integrin a v b 3 receptor. A 190 Kda protein that is phosphorylated in tyrosines as a result of PDGF receptor activity also binds to a v b 3 receptor, suggesting that there may be cooperation between this integrin and the PDGF pathway (Schneller et al., 1997) .
Regulation of cell cycle progression
Recent studies have indicated that cell adhesion is speci®cally required for the induction of cyclin D1 and for the activation of cyclin E-cdk2 complex in earlymid G1 phase (Fang et al., 1996) . Although cyclin D1 is regulated by cell adhesion at both the transcriptional and translational levels, the eect of cell adhesion on cyclin E-cdk2 activity appears to be indirect and mediated by downregulation of the cdk inhibitors p21 and p27 (Zhu et al., 1996) . These ®ndings suggest several mechanisms by which integrin engagement could regulate the cell cycle.
Regulation of cell migration
Recently David Cheresh and coworkers have provided evidence that integrin mediated activation of ERKs in¯uence the cells' motility machinery by phosphorylating and thereby enhancing myosin light chain kinase (MLCK) activity leading to phosphorylation of MLC (Klemke et al., 1997) . In vitro assays indicate that ERK can phosphorylate MLCK and ERKphosphorylated MLCK displays an enhanced capacity to phosphorylate MLC in a calmodulin dependent manner. In summary, it is clear that growth factor receptors as well as integrin receptors in¯uence the activity of one or more members of the MAP kinase family of signaling molecules. While MAP kinase signaling has been associated with the regulation of gene transcription events, David Cheresh's work clearly demonstrates that MAP kinase can promote cell migration on the ECM in a transcription-independent manner.
Role of integrins in cell survival signaling mechanisms
One important function of the integrin signaling pathways is to regulate anchorage dependence. Many mammalian cells are dependent on adhesion to the extracellular matrix for their continued survival. Early studies used ®broblasts which become growth inhibited in suspension, but remain viable. More recent studies have shown that certain specialized cell types such as endothelial cells and epithelial cells, when detached from substrate undergo apoptosis (Frisch and Francis, 1994; Meredith et al., 1993; Frisch and Ruoslahti, 1997; Meredith and Schwartz, 1997) . This phenomenon is referred to as`anoikis' from the greek for homelessness. Anoikis is a mechanism to insure that cells which are displaced from their natural environment are eliminated. Tumor cells are characterized by their ability to grow in the absence of contacts with the extracellular matrix. Cell-detachment induced anoikis does not occur in cells expressing activated Src or Ras oncogenes. Hence, these oncogenes must therefore be able to provide a constitutive signal normally originating from integrin receptors.
The ability of the extracellular matrix to promote cell survival appears to be mediated by at least two distinct signaling pathways. Studies on the role of Shc in integrin signaling have indicated that in cells adhesion mediated by integrins not linked to Shc, results not only in cell cycle arrest, but also in apoptotic cell death (Wary et al., 1996; Giancotti, 1997) . In agreement with a critical role for Shc signaling in protection from apoptosis, a dominant negative form of Shc has been shown to induce apoptotic cell death in primary endothelial cells plated on ®bronectin in the presence of mitogens (Wary et al., 1996; Giancotti, 1997) .
Role of phosphoinositide 3-Kinase and PKB/Akt in anoikis
Julian Downward's group studied the mechanism by which activated RAS oncogene protects MDCK epithelial cells from anoikis upon removal from extracellular matrix (Khwaja et al., 1997) . Their results suggest a following model of integrin signaling to the apoptotic machinery in untransformed epithelial cells. Cellular adhesion through integrins results in the activation of PI-3 kinase independently of signals from serum factors. The PI-3 kinase lipid products provide a protective signal acting through PKB/Akt which blocks entry into apoptosis. When epithelial cells are detached from the matrix, PI-3 kinase and PKB/Akt become inactive even in the presence of serum factors and an apoptotic pathway is engaged. RAS activation leads to the constitutive activation of PI-3 kinase, PKB/Akt pathway accounting for the survival of RAS-transformed cells in the absence of adhesion to extracellular matrix. PI-3 kinase acting through PKB/Akt is therefore implicated as a key mediator of the aberrant survival of RAS-transformed epithelial cells in the absence of attachment. Interestingly, introduction of activated forms of the PI3 K p110 subunit, or of AKT rescued the MDCK cells from anoikis.
As with other signaling mechanisms, the PI-3 kinase and PKB/Akt pathway is also activated upon growth factor stimulation and mediates the cell survival mechanism in the absence of growth factor stimulation (Kennedy et al., 1997; Marte and Downward, 1997) . The mechanism by which integrin engagement leads to PI-3 kinase activation in normal cells is not known. One mechanism may be through FAK as this kinase has been found to associate with the SH2 domains of p85 of PI-3K, so it may contribute to the constitutive activation of PI-3 kinase. Alternatively, as PI3-K is a major target eector of RAS (RodriguezViciana et al., 1994) , the activation of PI3-K by integrins could be mediated by the ability of Shc to activate RAS. Recent studies by King et al. (1997) have shown that integrin-mediated Erk-2, Mek-1 and Raf-1 activation but not Ras-GTP loading, was inhibited by PI-3K inhibitors demonstrating that PI-3K may function upstream of Raf-1 in integrin-mediated activation of Erk-2. Growth factor stimulation and integrin engagement leads to the stimulation of PI-3 kinase activity which results in the production of phosphatidyl inositol (3,4,5) triphosphate and Ptd Inositol (3,4)P 2 (Franke et al., 1995) . The binding of pleckstrin homology (PH) domain of PKB/Akt to these phosphoinositides both recruites PKB/Akt to the plasma membrane and in the case of PI(3,4)P2 directly stimulates its kinase activity (Franke et al., 1997a, b) . Full activation of PKB/Akt requires phosphorylation of Thr 308 by PDK1 and Ser 473by PDK2 (Alessi et al., 1996 (Alessi et al., , 1997 . Activated PKB/Akt phosphorylates substrates resulting in a variety of biological eects including suppression of apoptosis. Figure 4 summarizes the integrin-mediated signaling pathways leading to cell proliferation and cell survival.
Role of cell shape in anoikis
Cell adhesion to matrix causes dramatic changes in cell shape. Therefore, the question arises, does the cytoskeletal organization and associated cell shape ± as opposed to integrin signaling per se ± suppress anoikis? Two series of studies speci®cally address this issue of cell shape and cell spreading in anoikis. Endothelial cells that were placed in suspension underwent anoikis. Addition of microbeads coated with RGD peptides that were too small to permit cell spreading did not rescue these cells. However, plastic surfaces coated with RGD peptides rescued cells from anoikis eciently (Re et al., 1994) . These results suggest that mere attachment of cells through integrins is insucient for rescue and that cell shape changes are required.
Recently in an interesting study the role of cell spreading was studied using a system in which the total surface area available for cell attachment was kept constant while forcing cells either to remain round or spread out . This was accomplished by the use of microfabricated surfaces composed of islands of adhesive surface interspersed at varying distances from one another. When endothelial cells were cultured on these surfaces, round cells were found to be susceptible to apoptosis, whereas cells forced to stretch over widely dispersed small islands survived and proliferated . These results again provide evidence that cell spreading following cell attachment is crucial to rescue cells from anoikis.
Dierent cells may dier in their ability to utilize speci®c integrins to activate the antiapoptotic mechanism. Recent studies using CHO cells engineered to express either a 5 b 1 or a v b 1 integrin as their ®bronectin receptor have shown that only those cells expressing a 5 b 1 survived in serum free cultures (Zhang et al., 1995) . This response was associated with an elevated expression of the antiapoptotic protein Bcl-2. Other integrins such as a v b 1 or a v b 3 and various b 1 integrins fail to rescue cells from apoptosis under these conditions. It is possible that under other conditions cells depend on other integrins for survival (Brooks et al., 1994; Boudreau et al., 1995) . Dierent cell types may dier in their integrin dependence under the same conditions. Thus vascular endothelial cells seem to depend on a v b 3 receptor for their survival (Brooks et al., 1994) . Inhibition of a v b 3 function during angiogenesis with anti-a v b 3 antibodies both inhibited proliferation and induced apoptosis, whereas treatment with antibodies that block b 1 integrin function did not (Brooks et al., 1994) . Similarly, prevention of interactions of mammary epithelium with the matrix by anti-b 1 integrin antibodies both inhibited proliferation and induced apoptosis (Boudreau et al., 1995) . These results suggest that the same integrin might connect to dierent pathways in dierent cell types and that a given integrin could provide a survival signal in one cell type and an anoikis signal in another. A possible physiological signi®cance of the integrinselective apoptosis phenomenon is that it may prevent cells from attaching to inappropriate places in the body, because attachment through the wrong integrin would induce apoptosis.
Role of integrins in cell transformation
It is clear from the above discussion that cells require both adhesion to immobilized matrix proteins and stimulation by serum or growth factors in order to proliferate. An important conclusion of these studies reviewed above is that signaling pathways activated by growth factor receptors and integrin receptors, ultimately converge to determine cell cycle progression. By contrast, tumor cell proliferation is generally independent of both adhesion and serum though anchorage independence is the feature that correlates best with tumorigenicity in vivo (Freedman and Shin, 1974) . Proteins encoded by the oncogenes are generally components of the normal growth regulatory pathways that when overexpressed or mutated lead to irreversible activation of these pathways. Many oncogene encoded proteins also activate the integrin mediated pathways mainly through the Rho family proteins. Speci®cally, activated RAS has been shown to activate the cell morphology pathway through RAC and recent studies have shown that activation of both the cell morphology pathway and ERK pathway are essential for transformation (Joneson et al., 1996) . Constitutive activation of both integrin-mediated and growth factor pathways would be necessary to elicit serum and anchorage-independent status to the transformed cells. Activation of a step on the growth factor portion only should lead to enhanced proliferation but not anchorage-independent growth. Thus ®broblasts transformed by Raf and constitutively active MEK grow very poorly in an anchorage-independent manner (Mansour et al., 1994, and CC Kumar unpublished data) . Activated Rac and Rho proteins have been shown to synergize with Raf to eciently transform ®broblast cells, suggesting that Rac and Rho proteins are components of a separate pathway. Activation of a step on an integrin pathway prior to convergence would be expected to lead to anchorage-independent but serum-dependent growth. Thus oncogenes such as dbl and lbc which function as constitutively active guanine nucleotide exchange factors for the Rho family of proteins, induce anchorage-independent but serumdependent growth . lbc and dbl were identi®ed by their ability to induce focus formation and tumorigenicity in vivo when expressed in 3T3 cells (Toksoz and Williams, 1994; Eva and Aaronson, 1985) . Thus both lbc and dbl transformed cells show the same serum-dependence as control cells. These studies show that anchorage-independence and serum-independence can be separated. Understanding the mechanisms by which tumor cells gain the anchorage-independence status is an important area of investigation and may lead to the identi®cation of novel targets for drug discovery.
Summary and therapeutic applications
An important conclusion from the studies reviewed above is that the signaling pathways activated by growth factor receptors and integrin receptors are extensively intertwined, most importantly at the level of Ras, PI-3K and FAK. In addition, certain integrins physically form complexes with growth factor receptors. Many signaling intermediates interact with and receive signals from various upstream elements and bind to a large number of downstream target eectors. Although much has been learned about integrin signaling, important questions remain concerning the circuitry responsible for the crosstalk among signals triggered by dierent integrins and integration of signals from integrins and growth factor receptors. Finally, an analysis of mechanisms by which tumor cells survive and proliferate in the absence of signals from the integrins will be an important area of investigation.
Research on integrin receptors has also led to a number of therapeutic applications and targets for tumor therapy. One integrin-directed drug, an anti-b3 integrin antibody for the prevention of arterial restenosis, has reached the market place. Several other integrin based drugs such as the peptides containing the integrin-binding RGD sequence (Ruoslahti, 1996) , and mimics of such peptides that speci®cally block individual integrins are also under development. These drugs target thrombosis (a IIb b 3 in platelets (Pierschbacher et al., 1994) , osteoporosis (a v b 3 in osteoclsts (Flores et al., 1992) ) and tumor-induced angiogenesis (a v b 3 in neovascular endothelial cells (Brooks et al., 1994) . In a recent exciting study, Ruoslahti's group used the in vivo selection of phage display libraries to isolate peptides that home speci®cally to tumor blood vessels. Two of these peptides ± one containing a v integrin-binding Arg-Gly-Asp motif and the other an Asn-Gly-Arg motif ± were conjugated to the anticancer drug doxorubicin to demonstrate enhanced ecacy of the drug against human breast cancer xenografts in nude mice (Pasqualimi et al., 1997) . These peptidedrug conjugates exhibited signi®cantly less toxicity, suggesting that it may be possible to develop targeted chemotherapeutic strategies based on the selective expression of integrin receptors in tumor vasculature.
In summary, recent studies on integrins have greatly increased our understanding of the central biological phenomena, such as anchorage-dependence, tumorinduced angiogenesis and tumor metastsis, as well as generated a number of possible approaches to new therapies for cancer.
